|
Dec 4
|
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
|
|
Dec 4
|
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
|
|
Dec 2
|
An Important History Lesson for Gene-Editing Investors
|
|
Dec 2
|
5 Top Stocks to Buy Before 2024
|
|
Dec 1
|
5 Best Performing Stocks of the Top ETF of November
|
|
Dec 1
|
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist
|
|
Nov 29
|
If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names
|
|
Nov 29
|
Here's Why CRISPR Therapeutics AG (CRSP) is a Great Momentum Stock to Buy
|
|
Nov 29
|
What's Next For Gene-Editing Darling Crispr After Its 'Historic' First-Ever Approval?
|
|
Nov 8
|
CRISPR Therapeutics Stock Earns IBD Stock Rating Upgrade
|
|
Nov 8
|
Why CRISPR Therapeutics Stock Could Be About to Take Off
|
|
Nov 8
|
Company News for Nov 8, 2023
|
|
Nov 7
|
Why CRISPR Therapeutics Stock Crushed the Market Today
|
|
Nov 7
|
CRISPR Therapeutics (CRSP) Q3 Loss Narrower Than Expected
|
|
Nov 7
|
CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 200-Day Moving Average
|
|
Nov 6
|
CRISPR Therapeutics AG (CRSP) Reports Q3 2023 Financial Results, Highlights Progress in ...
|
|
Nov 6
|
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
|
|
Nov 6
|
Investors in CRISPR Therapeutics (NASDAQ:CRSP) from three years ago are still down 49%, even after 31% gain this past week
|
|
Nov 6
|
Is Connect Biopharma Holdings (CNTB) Outperforming Other Medical Stocks This Year?
|
|
Nov 6
|
CRISPR Therapeutics Announces Preclinical Data at the American Heart Association (AHA) Scientific Sessions 2023
|